- Home
- LOPE vs LIVN Comparison
LOPE vs LIVN Comparison
Compare LOPE & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOPE | LIVN |
|---|---|---|
| Founded | 1949 | 1987 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.3B |
| IPO Year | 2008 | 2015 |
Fundamental Metrics
Financial Performance| Metric | LOPE | LIVN |
|---|---|---|
| Price | $160.97 | $77.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $194.00 | $90.55 |
| AVG Volume (30 Days) | 266.6K | ★ 604.7K |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.57 | 2.33 |
| Revenue | ★ $511,257,000.00 | N/A |
| Revenue This Year | $5.60 | $9.65 |
| Revenue Next Year | $6.15 | $7.11 |
| P/E Ratio | $35.32 | ★ $33.68 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $134.27 | $48.82 |
| 52 Week High | $223.04 | $85.76 |
Technical Indicators
Market Signals| Indicator | LOPE | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 66.75 | 51.96 |
| Support Level | $160.00 | $77.28 |
| Resistance Level | $175.09 | $82.39 |
| Average True Range (ATR) | 3.83 | 1.95 |
| MACD | 0.68 | 0.33 |
| Stochastic Oscillator | 88.16 | 69.65 |
Price Performance
Historical ComparisonAbout LOPE Grand Canyon Education Inc.
Grand Canyon Education Inc is a publicly traded education services company dedicated to serving colleges and universities. GCE's university partner is Grand Canyon University, an Arizona non-profit corporation that operates a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases, and certificates across nine colleges, both online and on the ground at its campus in Phoenix, Arizona, and at four off-site classroom andlaboratory sites. The Company generates all of its revenue through service agreements with its university partners.
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives approximately half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.